Aditxt, Inc. Interest Expense
Aditxt, Inc. (ADTX) reported Interest Expense of $740.30 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2022-11-14
- Aditxt, Inc. interest expense for the quarter ending 2022-09-30 was $669.47K.
- Aditxt, Inc. interest expense for the quarter ending 2021-12-31 was $0.00.
- Aditxt, Inc. interest expense for the quarter ending 2020-12-31 was $0.00.
- Aditxt, Inc. interest expense for fiscal 2021 was $15.79K, a 170.27% increase from fiscal 2020.
- Aditxt, Inc. interest expense for fiscal 2020 was $5.84K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $669.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $740.30K 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $70.83K 10-Q · filed 2022-08-15 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $15.79K 10-K · filed 2022-03-31 | ||
| 2021-09-30 | $15.79K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $5.84K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $5.84K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |